Chronic News and Research

RSS

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

A recent study discusses the use of commensal bacteria in the gut and/or respiratory tract to deliver viral antigens to the host, thus acting as vaccines

19 Jul 2022

First-of-its-kind roadmap reveals how stem cells become sensory interneurons

Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have developed a first-of-its-kind roadmap detailing how stem cells become sensory interneurons - the cells that enable sensations like touch, pain and itch.

19 Jul 2022

New data shows the substantial protection offered by third and fourth COVID-19 vaccine doses

A third and fourth COVID-19 vaccine dose offered substantial protection among adults with healthy immune systems who were eligible to receive them during Omicron variant evolution in early 2022, according to a new MMWR published today.

19 Jul 2022

Tissue nanotransfection technology can serve as a non-viral, topical, gene-editing delivery device, research shows

The Indiana Center for Regenerative Medicine and Engineering (ICRME) at Indiana University School of Medicine is home to tissue nanotransfection (TNT) regenerative medicine technology that achieves functional tissue reprogramming in the live body.

19 Jul 2022

Six-country African study highlights the potential dangers of getting COVID-19 during pregnancy

A new study involving hospitalized women in six African countries from the University of Maryland School of Medicine's (UMSOM) Institute of Human Virology (IHV) showed that pregnant women with SARS-CoV-2, the virus that causes COVID-19, had double the risk of being admitted to the intensive care unit (ICU) and four-times the risk of dying in-hospital than pregnant women who did not have COVID-19.

19 Jul 2022

Vast majority of Brits concerned about equal access to healthcare following pandemic, says 3M

80% of Brits say ensuring equal access to quality healthcare is a top priority for society in the next five years.

From 3M 19 Jul 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application to the European Medicines Agency for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 19 Jul 2022

Study: Air pollution responsible for 2,780 deaths and cognitive loss in children in Massachusetts

Air pollution remains a silent killer in Massachusetts, responsible for an estimated 2,780 deaths a year and for measurable cognitive loss in Bay State children exposed to fine particulate pollutants in the air they breathe, according to a new study by researchers at Boston College's Global Observatory on Planetary Health.

18 Jul 2022

Decline in mental health during pregnancy throughout the COVID-19 lockdown period

A new study examined the changes in the mental state of pregnant women over the first COVID-19-related lockdown in France, and the persistence of anxiety-related symptoms over the two months following the end of the lockdown.

18 Jul 2022

Aegis Sciences to commence testing for monkeypox using CDC's orthopoxvirus test

Starting today, Aegis Sciences will begin testing for monkeypox using CDC's orthopoxvirus test, which detects most non-smallpox related orthopoxviruses, including monkeypox virus.

18 Jul 2022

Low rate of COVID-19 vaccination among high-risk pregnant women

A new study examines the feelings of pregnant women towards the COVID-19 vaccine.

17 Jul 2022

Alcohol consumption does not provide any health benefits, presents many risks for young people

Young people face higher health risks from alcohol consumption than older adults, according to a new analysis published in The Lancet.

15 Jul 2022

Quest Diagnostics starts testing for monkeypox with a real-time PCR test

Starting today, Quest Diagnostics will begin testing for monkeypox. The company has developed a real-time polymerase chain reaction (PCR) test that uses patient swab specimens to qualitatively detect non-variola orthpoxviruses and monkeypox virus DNA.

15 Jul 2022

Chemokine-DNA nanoparticles can induce chronic, dysfunctional immune responses

Small proteins, called chemokines, that direct immune cells toward sites of infection can also form DNA-bound nanoparticles that can induce chronic, dysfunctional immune responses, according to a new study by researchers at Weill Cornell Medicine and Hospital for Special Surgery (HSS).

15 Jul 2022

Study: Prescribing rate of non-opioid pain medications increased after 2016 CDC guideline

After the Centers for Disease Control and Prevention released a guideline for prescribing opioids to patients experiencing chronic pain in 2016, the prescribing rate of non-opioid pain medication increased each year above and beyond what would be expected based on the preexisting trends, a new study finds.

15 Jul 2022

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Forget covid-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics.

15 Jul 2022

Evidence for a specific anti-inflammatory metabolic signature in long-COVID

A recent research paper posted to the medRxiv* preprint server illustrated anti-inflammatory and hypo-metabolic fingerprints in long coronavirus disease (COVID) syndrome (LCS) using pan-omics plasma assessments.

15 Jul 2022

Y chromosome loss in men can lead to deadly heart failure, research shows

The loss of the male sex chromosome as many men age causes the heart muscle to scar and can lead to deadly heart failure, new research from the University of Virginia School of Medicine shows.

14 Jul 2022

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

The COVID-19 pandemic pushed back years of progress made in combating antimicrobial resistance (AR) in the United States.

14 Jul 2022

Risk profiles in adults with cardiovascular disease fail to improve despite advances guidelines and treatments

In an analysis of medical information of more than 6,000 American adults with a history of cardiovascular disease (CVD), researchers at Johns Hopkins Medicine conclude that CVD risk "profiles" in secondary prevention have failed to improve over the last two decades.

14 Jul 2022

Chronic News and Research

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

First-of-its-kind roadmap reveals how stem cells become sensory interneurons

New data shows the substantial protection offered by third and fourth COVID-19 vaccine doses

Tissue nanotransfection technology can serve as a non-viral, topical, gene-editing delivery device, research shows

Six-country African study highlights the potential dangers of getting COVID-19 during pregnancy

Vast majority of Brits concerned about equal access to healthcare following pandemic, says 3M

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Study: Air pollution responsible for 2,780 deaths and cognitive loss in children in Massachusetts

Decline in mental health during pregnancy throughout the COVID-19 lockdown period

Aegis Sciences to commence testing for monkeypox using CDC's orthopoxvirus test

Low rate of COVID-19 vaccination among high-risk pregnant women

Alcohol consumption does not provide any health benefits, presents many risks for young people

Quest Diagnostics starts testing for monkeypox with a real-time PCR test

Chemokine-DNA nanoparticles can induce chronic, dysfunctional immune responses

Study: Prescribing rate of non-opioid pain medications increased after 2016 CDC guideline

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Evidence for a specific anti-inflammatory metabolic signature in long-COVID

Y chromosome loss in men can lead to deadly heart failure, research shows

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

Risk profiles in adults with cardiovascular disease fail to improve despite advances guidelines and treatments

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News